UNSPSC 51452302: Piperonyl

This classification denotes a cyclic ether carcinogen with the molecular formula C19H30O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LWK91TU9AH, chemically known as 4,5-methylenedioxy-2-propylbenzyldiethyleneglycol butyl ether but generally known as piperonyl butoxide, which bears US NIH Compound Identifier 5794. European Medicines Agency schedules Piperonyl butoxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14893MIG. SMILES: CCCCOCCOCCOCC1=CC2=C(C=C1CCC)OCO2.

UNSPSC 51452302 Piperonyl, a Commodity code, does not align with the state and local procurement activity currently tagged under it. The recent opportunities posted to this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiatives, medical and first aid supplies for fire departments, and generic pharmaceuticals and OTC products — none of which are piperonyl or piperonyl-derived compounds. The code shows minimal relevant recent activity; the opportunities present reflect either a classification mismatch or sporadic tagging inconsistency rather than a coherent product family.

The issuing bodies span multiple jurisdictions: Seminole County, Florida (health procurement); the Texas Health and Human Services Commission (pharmacy benefit strategy); the City of Tampa (emergency medical supplies); and the Minnesota Department of Administration through the Minnesota Multistate Cooperative Purchasing Alliance (pharmaceutical distribution). Geographic spread includes Florida, Texas, Minnesota, and Oregon. Representative recent solicitations include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2026) for naloxone and drug deactivation systems with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for medical and first aid supplies estimated at $700,000 and designated as a sheltered market for certified Small Local Business Enterprises; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic pharmaceuticals and OTC products distributed through authorized wholesalers effective July 1, 2026. The code does not support pursuit based on the current tagging pattern.